News
The Food and Drug Administration has issued a long-awaited approval of Novavax’s COVID-19 vaccine but with unusual restrictions.
The approval of Moderna's Spikevax for kids at higher risk of contracting the disease continues the company's regulatory ...
Moderna's Spikevax receives FDA approval for use in high-risk children; Pfizer, BioNTech appeal U.K. ruling in COVID-19 ...
The Food and Drug Administration (FDA) granted full approval on Thursday to Moderna’s COVID-19 vaccine for children, making it the first COVID shot for kids aged 6 months to 11 years old that is ...
A top official at the Food and Drug Administration recently overruled government scientists on the availability of two ...
The FDA's Dr. Vinay Prasad said that he disagreed with the agency's career vaccine reviewers about COVID shot approvals.
The US Food and Drug Administration’s top vaccine official overrode agency experts in May to recommend against the broad use ...
FDA vaccine head Vinay Prasad restricted Moderna and Novavax COVID vaccines to high-risk groups, overriding staff advice amid ...
The new memos from the Food and Drug Administration show how the agency’s vaccine chief, Dr. Vinay Prasad, personally ...
Peter Marks, who headed the FDA’s Center for Biologics Evaluation and Research before being forced to resign in March, said ...
The mRNA drug developer said it will begin discussing approval with the FDA, which has adopted stricter vaccine review ...
Hosted on MSN1mon
FDA approves Novavax COVID-19 shot but with unusual restrictionsWASHINGTON (AP) — The Food and Drug Administration has issued a long-awaited approval of Novavax’s COVID-19 vaccine but with unusual restrictions. Novavax makes the nation’s only traditional ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results